Pancreatic Cancer Research

ResearcherQueen Mary University of LondonNo recent work listed

Kate E Lines

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0764-8681; OpenAlex author ID A5050960450. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer. First author DOI 10.1038/s41388-023-02851-y↗
  2. S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells. Co-author DOI 10.1007/s10585-012-9532-y↗
  3. S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells. Co-author DOI 10.1016/j.ajpath.2011.12.031↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tatjana Crnogorac‐Jurcevic · 3 shared papers, 2012–2023 · strength 0.34
  2. Kirtiman Srivastava · 1 shared paper, 2023 · strength 0.26
  3. Claude Chelala · 2 shared papers, 2012–2013 · strength 0.07
  4. Makoto Sunamura · 1 shared paper, 2013 · strength 0.04
  5. Sayka Barry · 1 shared paper, 2013 · strength 0.04
  6. Hemant Mahendrakumar Kocher · 1 shared paper, 2012 · strength 0.03
  7. John F. Marshall · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.